MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2021–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE CONAFAY GROUP, LLC	—	23

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	22
SENATE	22
Office of Science & Technology Policy (OSTP)	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	23
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	23

Bills Explicitly Cited (16)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3437118th Congress

Colorado Outdoor Recreation and Economy Act

2023 · second_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act.

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437118th Congress

Colorado Outdoor Recreation and Economy Act

2023 · second_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act.

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437118th Congress

Colorado Outdoor Recreation and Economy Act

2023 · first_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act.

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437118th Congress

Colorado Outdoor Recreation and Economy Act

2023 · first_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act.

Client expense: — · Firm income: —

Matched citations: HR3437

Show 12 more cited filings

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · fourth_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act.

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · fourth_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act.

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · third_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · third_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · second_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · second_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · first_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2022 · first_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2021 · fourth_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2021 · fourth_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2021 · third_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

eek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

H.R. 3437117th Congress

LOANS for Biomedical Research Act

2021 · third_quarter · Firm: THE CONAFAY GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Seek approval for regulatory support; HR3437; Loans Act

Client expense: — · Firm income: —

Matched citations: HR3437

Source: Senate LDA

MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) — Lobbying Disclosure | Poliscope